DTYMK Antibodies

Santa Cruz Biotechnology features a diverse variety of DTYMK monoclonal antibodies for investigating deoxythymidylate kinase (DTYMK) in cellular processes. DTYMK monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DTYMK is a crucial enzyme involved in the synthesis of deoxythymidine monophosphate, a building block of DNA. DTYMK activity is essential for DNA replication and repair, playing a key role in cell proliferation and survival. Research has shown that DTYMK expression levels vary significantly across different tissue types. Dysregulation of DTYMK has been linked to various diseases, including cancer, highlighting its significance as a potential therapeutic target. Current studies are exploring DTYMK's role in cell cycle regulation and DNA damage response pathways. Understanding DTYMK function may lead to new insights in cancer biology and treatment strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of DTYMK's biological significance and therapeutic potential.